The company highlighted in today’s article – a direct-to-consumer telemedicine and wellness company – is the most bought OTC stock by insiders in the past month, including a purchase of over 100,000 shares by one of its directors. As such, the author advises that it may be a good time to revisit the stock in question – and outlines some potential action to take. For more, CLICK HERE.